Researchers at the NIH and Emory School of Medicine have completed the first minimally invasive coronary artery bypass of the ...

Marengo CIMS Hospital has achieved a significant clinical milestone by completing six Renal Denervation (RDN) procedures, among one of the highest in India and the highest in Gujarat. The procedures ...

Peripheral arterial disease (PAD) is a common manifestation of systemic atherosclerosis. Although clinical history in conjunction with ankle–brachial index and evaluation of segmental ...

Learn more about whether Artivion, Inc. or UFP Technologies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A stent designed specifically for infants and young children with congenital heart disease has demonstrated strong safety and ...

A late-breaking study drawing on more than 15 years of national outcomes data from the STS Adult Cardiac Surgery Database ...

The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz., Jan. 6, 2026 ...

W.L. Gore & Associates has received FDA approval for the Gore Viabahn Fortegra Venous Stent — the first device indicated to treat deep venous disease in the inferior vena cava, as well as the iliac ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

As an interventional radiologist at Palmetto General Hospital, I have over 15 years of experience treating venous thromboembolic disease and have comp ...

Flow-diverting stents for carotid-ophthalmic aneurysms show a favorable retinal safety profile with only transient, asymptomatic changes observed.

Annually, an estimated 1 million patients undergo heart surgery worldwide. Unfortunately, stroke continues to be a frequent complication of cardiac surgery, with the specific cerebrovascular risk ...